Tag: drug

Posted on

AstraZeneca wins temporary block on Actavis asthma drug – 4-traders (press release)


IBTimes.co.uk

AstraZeneca wins temporary block on Actavis asthma drug
4-traders (press release)
AstraZeneca (>> AstraZeneca plc) has secured a temporary block on U.S. sales of generic copies of its Pulmicort Repsules asthma drug by Actavis (>> Actavis Inc). AstraZeneca (>> AstraZeneca plc) has secured a temporary block on U.S. sales of generic …
AstraZeneca Loses US Patent Protection for Asthma DrugFox Business
AstraZeneca's Kid Asthma Drug Patent Invalid, Judge SaysLaw360 (subscription)
Blow for AstraZeneca in USA over asthma drug patentsPharmaTimes
IBTimes.co.uk –Globes –Evening Standard
all 37 news articles »

View full post on asthma – Google News

Posted on

AstraZeneca Loses US Patent Protection for Asthma Drug – Fox Business


IBTimes.co.uk

AstraZeneca Loses US Patent Protection for Asthma Drug
Fox Business
A patent protecting AstraZeneca's (AZN) Pulmicort Respules asthma drug in the U.S. was deemed invalid on Tuesday, paving the way for a generic version of the drug to hit store shelves. The company said on Tuesday a district court in New Jersey ruled in …
AstraZeneca Loses US Patent on Asthma DrugIBTimes.co.uk
US court blow for AstraZeneca on asthma drugEvening Standard
Teva loses exclusivity on AstraZeneca asthma drugGlobes
IFA Magazine –Financial Times –Bloomberg
all 22 news articles »

View full post on asthma – Google News

Posted on

AstraZeneca Loses US Patent on Asthma Drug – IBTimes.co.uk


IBTimes.co.uk

AstraZeneca Loses US Patent on Asthma Drug
IBTimes.co.uk
Apotex and Actavis had received approval from the US Food and Drugs Administration (FDA), but they are yet to launch generic versions of the medicine, which is used to control and prevent asthma symptoms in children aged between 12 months to 8 years.
US court blow for AstraZeneca on asthma drugEvening Standard
AstraZeneca to contest US court ruling over asthma medicineIFA Magazine
AstraZeneca loses US drug patent judgmentFinancial Times
Bloomberg –GlobalPost
all 17 news articles »

View full post on asthma – Google News

Posted on

Study: Drug normally used to treat severe bronchial asthma beneficial for … – News-Medical.net

Study: Drug normally used to treat severe bronchial asthma beneficial for …
News-Medical.net
An international study involving dermatologists from the Hospital del Mar and Spanish subjects has concluded that a drug normally used to treat severe bronchial asthma caused by allergies (Omalizumab) rapidly eliminates the symptoms of spontaneous …

and more »

View full post on asthma – Google News

Posted on

Glenmark Generics recalls anti-asthma drug from US market – Hindu Business Line


Hindu Business Line

Glenmark Generics recalls anti-asthma drug from US market
Hindu Business Line
Glenmark Generics is recalling from the US market multiple lots of Montelukast Sodium tablets (10 mg), used in treatment of chronic asthma and prophylaxis, on “off-odour” complaints, according to US Food and Drug Administration. Montelukast Sodium …

and more »

View full post on asthma – Google News

Posted on

Cytos Rises After Asthma Drug Succeeds in Trial: Zurich Mover – Bloomberg

Cytos Rises After Asthma Drug Succeeds in Trial: Zurich Mover
Bloomberg
In a trial among 63 patients in Germany, those treated with the drug, CYT003, had improved control of their asthma after treatment with inhaled corticosteroids stopped, while those who received a placebo saw their disease worsen, Cytos said in a …
The Journal of Allergy and Clinical Immunology Publishes Phase 2a Study …PR Newswire (press release)

all 3 news articles »

View full post on asthma – Google News

Posted on

Asthma drug to make “massive difference” to thousands of Midland youngsters – Birmingham Mail

Asthma drug to make "massive difference" to thousands of Midland youngsters
Birmingham Mail
A wonder asthma drug could help thousands of children in the West Midlands breathe easier after health experts recommended it be used to treat under 11s for the first time. Dr Adel Mansur, consultant physician at Heartlands Hospital, said the treatment …

View full post on asthma – Google News

Posted on

UK health cost body backs Novartis asthma drug in fresh U-turn – Chicago Tribune

UK health cost body backs Novartis asthma drug in fresh U-turn
Chicago Tribune
LONDON (Reuters) – Britain's health cost-effectiveness watchdog NICE said it planned to recommend the use of Novartis's severe asthma drug Xolair after prevaricating for months over whether it should be paid for on the taxpayer-funded National Health …
Life-changing jab gives hope to asthma sufferersExpress.co.uk
Asthma treatment – double U-turnWebMD.Boots.com
NICE U-turn on Novartis' Xolair for asthmaPharmaTimes
OnMedica –The Daily Telegraph –GP online
all 10 news articles »

View full post on asthma – Google News